CB Therapeutics

CB Therapeutics

Closed: Apr. 2023

About this raise

CB Therapeutics, with a valuation of $45 million, is raising funds on Republic. The company has developed an advanced synthetic biology and cellular agriculture platform. The platform aims to discover, develop, and produce compounds to solve problems in the field of healthcare, food, mental health, and the environment. CB Therapeutics has a substantial patent portfolio with seven granted and 13 pending patents and has been generating revenues since 2022. She Ali Butt and Jacob Vogan founded CB Therapeutics in March 2015. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for small-scale manufacturing, hiring of laboratory personnel, and research and development.

Expand

Investment Overview

Not Funded: $0

Deal Terms

Total Commitments

Platform
Republic
Start Date
02/28/2023
Close Date
04/11/2023
Min. Goal
$25,000
Max Goal
$1,235,000
Min. Investment

$250

Security Type

SAFE

Company Stage

Growth Stage

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$45,000,000

Discount

20%

Company & Team

Company

Year Founded
2015
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Location
Carlsbad, California
Business Type
Growth
Company Website
Visit Website

Team

Employees
11
Prior Founder Exits?
No
Founder Name
Sher Ali Butt
Title
CEO & Board Member
Founder Name
Jacob Vogan
Title
Chief Scientific Officer

Funding data not publicly available

Financials

 Revenue
$2,014,066
as of FY2021
 Monthly Burn
$147,680
as of FY2021
 Runway
12.3 months
as of FY2021

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$2,014,066

$0

COGS

$0

$0

Tax

$3,017

$1,600

 

 

Net Income

$-1,772,158

$-2,278,343

Summary Balance Sheet

FY 2021 FY 2020

Cash

$1,810,709

$13,453

Accounts Receivable

$14,066

$0

Total Assets

$3,722,376

$910,015

Short-Term Debt

$287,110

$677,795

Long-Term Debt

$188,555

$730,988

Total Liabilities

$475,665

$1,408,783

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$7,600,000
VC Backed?
Yes
Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/11/2023 Republic $45,000,000 $0 SAFE Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
CB Therapeutics on Republic 2023
Platform: Republic
Security Type: SAFE
Valuation: $45,000,000

Follow company

Follow CB Therapeutics on Republic 2023

Buy CB Therapeutics's Deal Report

Warning: according to the close date for this deal, CB Therapeutics may no longer be accepting investments.

CB Therapeutics Deal Report

Get Kingscrowd's comprehensive report on CB Therapeutics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether CB Therapeutics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the CB Therapeutics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge